Malignant fibrous histiocytoma is the most common type of soft tissue sarcoma that forms around the bones. It originates from the tough fibrous tissue that makes up the tendons and ligaments. Due to the elasticity and flexibility of soft tissues, a fibrous histiocytoma can grow for a long time without causing noticeable symptoms. Thus, most tumours are only diagnosed when they grow large enough to cause an external swelling or lump. Unfortunately, when left untreated, this type of cancer can spread to the bones.
Patients who have been diagnosed with this type of malignant sarcoma should seek immediate medical care from oncologists who specialise in treating soft tissue cancers. Although cancer treatment is widely available, more and more cancer patients from all over the world are flying all the way to Southeast Asia to take advantage of affordable specialist care. While medical tourism is a flourishing trade in the United States and Europe, Southeast Asian hospitals are nevertheless standing out for their world-class medical care quality, easier tourist access, and competitive rates, which are up to 75% cheaper than in the West.
The first line of treatment for sarcoma involves surgically removing the growth followed by cancer therapy to destroy the remaining cancer cells. Singapore is popular for its cancer surgery mainly due to its internationally trained, highly skilled surgeons while Malaysia is known for its revolutionary treatments, such as stem cell therapy, which could be an alternative to chemotherapy and radiation therapy. Many of Thailand’s JCI-accredited hospitals, on the other hand, specialise in different types of cancer therapy, including brachytherapy and external beam radiation therapy.
For patients seeking treatment for malignant fibrous histiocytoma, Southeast Asia is definitely the emergent source of high standard oncology care. The region’s highly developed healthcare infrastructure and continuous investments in innovative cancer technologies can deliver the best possible treatment outcomes.